Using AI to Identify Combinations of Drugs to Fight COVID-19 with Daniel Cohen Pharnext

Published: April 28, 2020, 4:41 p.m.

Daniel Cohen, Founder, Pharnext discusses how the French biopharma company is using its artificial intelligence (AI) driven platform to identify drugs that have already been approved which can be used in combination to fight COVID-19.\xa0 Dr. Cohen who lead Pharnext as CEO for over a decade has recently left that role to become Chairman of Pharnext's Scientific Advisory Board in order to focus on his true passion--maximizing the potential of Pharnext's Pleotherapy platform.

#pharnext #pleotherapy #COVID19 #drugdiscovery #AI

Pharnext.com

Download the transcript